Immature human engineered heart tissues engraft in a guinea pig chronic injury model
Standard
Immature human engineered heart tissues engraft in a guinea pig chronic injury model. / von Bibra, Constantin; Shibamiya, Aya; Bähr, Andrea; Geertz, Birgit; Köhne, Maria; Stuedemann, Tim; Starbatty, Jutta; Horneffer-van der Sluis, Verena; Klostermeier, Ulrich C; Hornaschewitz, Nadja; Li, Xinghai; Wolf, Eckhard; Klymiuk, Nikolai; Krane, Markus; Kupatt, Christian; Hiebl, Bernhard; Eschenhagen, Thomas; Weinberger, Florian.
in: DIS MODEL MECH, Jahrgang 16, Nr. 5, dmm049834, 01.05.2023.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Immature human engineered heart tissues engraft in a guinea pig chronic injury model
AU - von Bibra, Constantin
AU - Shibamiya, Aya
AU - Bähr, Andrea
AU - Geertz, Birgit
AU - Köhne, Maria
AU - Stuedemann, Tim
AU - Starbatty, Jutta
AU - Horneffer-van der Sluis, Verena
AU - Klostermeier, Ulrich C
AU - Hornaschewitz, Nadja
AU - Li, Xinghai
AU - Wolf, Eckhard
AU - Klymiuk, Nikolai
AU - Krane, Markus
AU - Kupatt, Christian
AU - Hiebl, Bernhard
AU - Eschenhagen, Thomas
AU - Weinberger, Florian
N1 - © 2023. Published by The Company of Biologists Ltd.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Engineered heart tissue (EHT) transplantation represents an innovative, regenerative approach for heart failure patients. Late preclinical trials are underway, and a first clinical trial started recently. Preceding studies revealed functional recovery after implantation of in vitro-matured EHT in the subacute stage, whereas transplantation in a chronic injury setting was less efficient. When transplanting matured EHTs, we noticed that cardiomyocytes undergo a dedifferentiation step before eventually forming structured grafts. Therefore, we wanted to evaluate whether immature EHT (EHTIm) patches can be used for transplantation. Chronic myocardial injury was induced in a guinea pig model. EHTIm (15×106 cells) were transplanted within hours after casting. Cryo-injury led to large transmural scars amounting to 26% of the left ventricle. Grafts remuscularized 9% of the scar area on average. Echocardiographic analysis showed some evidence of improvement of left-ventricular function after EHTIm transplantation. In a small translational proof-of-concept study, human scale EHTIm patches (4.5×108 cells) were epicardially implanted on healthy pig hearts (n=2). In summary, we provide evidence that transplantation of EHTIm patches, i.e. without precultivation, is feasible, with similar engraftment results to those obtained using matured EHT.
AB - Engineered heart tissue (EHT) transplantation represents an innovative, regenerative approach for heart failure patients. Late preclinical trials are underway, and a first clinical trial started recently. Preceding studies revealed functional recovery after implantation of in vitro-matured EHT in the subacute stage, whereas transplantation in a chronic injury setting was less efficient. When transplanting matured EHTs, we noticed that cardiomyocytes undergo a dedifferentiation step before eventually forming structured grafts. Therefore, we wanted to evaluate whether immature EHT (EHTIm) patches can be used for transplantation. Chronic myocardial injury was induced in a guinea pig model. EHTIm (15×106 cells) were transplanted within hours after casting. Cryo-injury led to large transmural scars amounting to 26% of the left ventricle. Grafts remuscularized 9% of the scar area on average. Echocardiographic analysis showed some evidence of improvement of left-ventricular function after EHTIm transplantation. In a small translational proof-of-concept study, human scale EHTIm patches (4.5×108 cells) were epicardially implanted on healthy pig hearts (n=2). In summary, we provide evidence that transplantation of EHTIm patches, i.e. without precultivation, is feasible, with similar engraftment results to those obtained using matured EHT.
KW - Humans
KW - Guinea Pigs
KW - Animals
KW - Heart
KW - Myocytes, Cardiac
KW - Heart Ventricles
KW - Echocardiography
KW - Tissue Engineering/methods
KW - Cell Differentiation
KW - Myocardium
U2 - 10.1242/dmm.049834
DO - 10.1242/dmm.049834
M3 - SCORING: Journal article
C2 - 37272385
VL - 16
JO - DIS MODEL MECH
JF - DIS MODEL MECH
SN - 1754-8403
IS - 5
M1 - dmm049834
ER -